Bone Wiper Blade segmentation by application reflects the functional drivers of demand across clinical and research settings. Orthopedic surgery accounts for the largest share, as surgeons rely on the blade’s precision to remove residual bone tissue during joint replacement and trauma procedures; this segment contributes roughly 55 % of total market revenue. Veterinary surgery follows, representing 20 % of sales, where the same precision is required for large‑animal orthopedic interventions. Research & development laboratories, encompassing biomechanical testing and implant validation, generate 15 % of the market, driven by the need for consistent, contaminant‑free bone removal in controlled experiments. The residual 10 % is classified as other applications, including forensic analysis and educational cadaver labs, which, while smaller, provide niche growth opportunities. Collectively, these application categories define the market’s size hierarchy, and shifts in surgical volume or research funding directly re‑shape the overall Bone Wiper Blade market landscape. Emerging minimally invasive procedures are expected to increase blade utilization rates, while regulatory scrutiny on single‑use devices may influence procurement strategies across these segments.